Publications

Title

Author

Year

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of rec...

Murray, ML; Meadows, J; Doré, CJ; Copas, AJ; Haddow, LJ; Lacey, C; JIT, M; Soldan, K; Bennett, K; Tetlow, M; Nathan, M; Gilson, R;

2018

BMC medical research methodology, (2018).18 1 10.1186/s12874-018-0581-z.

Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.

Wilcox, CR; Bottrell, K; PATERSON, P; Schulz, WS; Vandrevala, T; LARSON, HJ; Jones, CE;

2018

Vaccine, (2018).36 50 10.1016/j.vaccine.2018.10.092.

Vaccine Safety Surveillance in Pregnancy Using Gaia Definitions for Neonatal Conditions: A Feasibility Assessment in Low- and Middle-Income Countries.

Stuurman, AL; Riera, M; Lamprianou, S; Perez-Vilar, S; Anderson, SA; MANGTANI, P; Devlieger, H; Verstraeten, T; Zuber, P; Maure, CG;

2018

DRUG SAFETY, (2018).41 11

Research and development of new tuberculosis vaccines: a review.

Schrager, LK; HARRIS, RC; Vekemans, J;

2018

F1000Research, (2018).7, 10.12688/f1000research.16521.2.

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13.

Reglinski, M; Ercoli, G; Plumptre, C; KAY, E; Petersen, FC; Paton, JC; WREN, BW; Brown, JS;

2018

NPJ vaccines, (2018).3 1 10.1038/s41541-018-0090-4.

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.

Hammitt, LL; Etyang, AO; Morpeth, SC; OJAL, J; Mutuku, A; Mturi, N; Moisi, JC; ADETIFA, IM; Karani, A; Akech, DO; OTIENDE, M; Bwanaali, T; Wafula, J; Mataza, C; Mumbo, E; Tabu, C; Knoll, MD; Bauni, E; Marsh, K; Williams, TN; Kamau, T; Sharif, SK; Levine, OS; SCOTT, JA G;

2018

Lancet, (2018).393 10186 10.1016/S0140-6736(18)33005-8.

Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.

JARVIS, CI; Altamirano, J; Sarnquist, C; EDMUNDS, WJ; Maldonado, Y;

2018

Clinical infectious diseases, (2018).67 suppl_ 10.1093/cid/ciy622.

Mathematical modelling of the epidemiological impact, cost-effectiveness and budget impact of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral presentation].

WEERASURIYA, C; Harris, R; BOZZANI, F; MCQUAID, C; KNIGHT, G; SUMNER, T; Gomez, GB; WHITE, R;

2018

International Journal of Tuberculosis and Lung Disease, (2018).22 11

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.

Pecenka, C; Debellut, F; Bar-Zeev, N; ANWARI, P; Nonvignon, J; Shamsuzzaman, M; CLARK, A;

2018

Vaccine, (2018).36 49 10.1016/j.vaccine.2018.10.068.

The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries.

VYNNYCKY, E; Papadopoulos, T; Angelis, K;

2018

Human vaccines & immunotherapeutics, (2018).15 2 10.1080/21645515.2018.1532257.